Kidswell Bio Corporation [4584.T]
TOKYO, Jun 30 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) disclosed updates on its major shareholder status as of March 31, 2026. According to the filing, Noritsu Koki Co., Ltd.
Remains the largest shareholder with direct ownership of 19.08% percent of the company's voting rights. As of March 31, 2026, Kidswell Bio was classified as an equity-method affiliate of Noritsu Koki Co., Ltd. Additionally, the company noted that as per the announcement made on May 28, 2026, another related party ceased to qualify as such effective immediately thereafter.
Regarding transactions with controlling shareholders, there were none reported. Kidswell Bio maintains independent operations while fostering cooperative relationships within the group. Any potential future dealings will adhere to fair conditions similar to general transactions, ensuring appropriate oversight through board deliberation to protect minority shareholders' interests.
🟡 Confidence: Standard AI-translated content.